| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 246,992 | 251,959 | 227,865 | 222,980 | | Cost of Revenue | 96,814 | 95,251 | 88,923 | 91,955 | | | Gross Profit | 150,178 | 156,708 | 138,942 | 131,025 | | | Operating Expenses | | Research Development | 17,914 | 16,967 | 13,881 | 14,915 | | Selling General and Administrative | 77,756 | 76,586 | 71,865 | 70,087 | | Non Recurring |
-
| 3,500 |
-
|
-
| | Others | 1,845 | 1,756 | 677 | 2,694 | | | | Total Operating Expenses |
-
| 98,809 |
-
|
-
| | | | Operating Income or Loss | 52,663 | 57,899 | 52,519 | 43,329 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,118 | 3,258 | 2,300 | 3,652 | | Earnings Before Interest And Taxes | 57,906 | 61,157 | 54,819 | 46,981 | | Interest Expense |
-
| (1,224) | 1,224 |
-
| | Income Before Tax | 57,906 | 62,381 | 53,595 | 46,981 | | Income Tax Expense | 15,804 | 17,011 | 14,396 | 13,128 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 42,102 | 45,370 | 39,199 | 33,853 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,102 | 45,370 | 39,199 | 33,853 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $42,102 | $45,370 | $39,199 | $33,853 |
|
0.10% Nasdaq 
Income Statement
